Home
|
Twitter
|
Register for Updates
|
Careers
About Us
Afirma
Pipeline
Library
Media
Contact Us
Media
Press Releases
News
Events
Media Kit
Links
Send Veracyte media related inquiries to
media@veracyte.com
.
Press Releases
Sharing Breaking News and Important Information
Genzyme and Veracyte Announce Expanded U.S. Availability of the Afirma® Thyroid FNA Analysis for Improved Thyroid Nodule Diagnosis
Apr 16 2012
Richard T. Kloos, MD, Joins Veracyte as Senior Medical Director
Apr 5 2012
Veracyte Appoints Mark Spring as Chief Financial Officer
Jan 31 2012
Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients
Jan 20 2012
Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
Jan 9 2012
New Data Suggest Veracyte’s Afirma® Gene Expression Classifier Cost-Effectively Resolves Inconclusive Thyroid Nodule FNA Biopsy Results
Sep 1 2011
New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples
Sep 15 2010
Veracyte Completes $28 Million Series B Round – One Step Closer to Commercializing First Molecular Diagnostic Product
Jun 9 2010
